Wei Dong Jiang
Fortune : 6 M $ au 31/08/2026
Fortune : 6 M $ au 31/08/2026
Wei Dong Jiang is the founder of two companies, Henlius Biopharmaceuticals, Inc. and Shanghai Henlius Biotech, Inc., both founded in 2009.
He held the title of Chief Scientific Officer & Vice President at Henlius Biopharmaceuticals, Inc. and Chief Scientific Officer & Senior Vice President at Shanghai Henlius Biotech, Inc. Dr. Jiang has a doctorate degree from the University of Giessen and an undergraduate degree from Zhejiang University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 720 955 ( 0,21% ) | 6 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Fondateur | 01/12/2009 |
| Sociétés | Poste | Fin |
|---|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Focuses on development and commercialization of mAb-based therapeutics | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
University of Giessen
University of Giessen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zhejiang University
Zhejiang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Focuses on development and commercialization of mAb-based therapeutics | Health Technology |
Shanghai Henlius Biotech, Inc.
Shanghai Henlius Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national